We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
On the 5 September 2016 the media reported that Venezuela has seen 143 987 cases of malaria from January 2016 through to 20 August 2016, this represents an increase of 72.2% over the same period in 2015. The majority of cases are from Bolivar, a large state in eastern Venezuela which borders Brazil and Guyana.
Additionally, the antimalarial drug artemisinin which is used to treat the parasite Plasmodium falciparum is reported to be running low in stock. Furthermore, in Bolivar both antimalarial drug stocks and diagnostic supplies are reported to be depleted.
(Via Outbreak News Today accessed 06/09/16)
Advice for Travellers
Clinicians should adhere to current guidance (SMAG and/or ACMP in UK) for malaria chemoprophylaxis for Venezuela. However, travellers should be made aware of the resurgence of malaria in Venezuela, and advised that mosquito bite avoidance should always be considered as the first line of defence against malaria and other mosquito-borne infections.
